Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
113.00    -2.00 (-1.74%)
Bid:
114.00
Ask:
116.00
Spread: 2.00 (1.754%)
Market Cap: £88.67m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Period end trading update

21 Jan 2010 07:00

RNS Number : 8908F
Xaar PLC
21 January 2010
 



FOR IMMEDIATE RELEASE

21 January 2010

Xaar plc

FULL YEAR TRADING UPDATE

Xaar plc ("Xaar"), the inkjet printing technology group headquartered in Cambridge, presents an update on trading performance for the year ended 31 December 2009.

Trading

Trading for the fourth quarter of 2009 and the year as a whole was in line with the Board's expectations and the financial results for the 12 months ended 31 December 2009 are expected to be in line with market expectations.

The trends reported in the IMS dated 14 October 2009 continued through to the year-end. OEM customers are continuing to develop digital printing machines incorporating Xaar's Platform 3 technology and, whilst some applications are now technically proven and contribute material revenue to Xaar, others still remain some way from full commercialisation. Xaar remains committed to providing its Platform 3 customers with the necessary support to bring these developments to a successful conclusion and has continued to incur some significant costs in doing this.

Sales of Platform 1 products continue to deliver the majority of Xaar's revenues through both new product launches and continuing sales of existing products, albeit at lower margins than seen historically. These lower margins are a direct result of the highly competitive nature of this market and, as is the case for Platform 3, higher than expected customer support costs for some of these products.

The project to transfer those manufacturing facilities located in Sweden to the Group's Huntingdon facility continues to be on track with completion scheduled for March 2011.

Whilst results for 2009 are expected to be in line with market consensus, the level of profitability reflected the benefits of the cost cutting programme previously implemented offset by the higher than anticipated product and customer support costs. The Board is continuing to take appropriate action to improve profitability and is planning on delivering improved results for 2010.

Cash

Net cash and cash equivalents at 31 December 2009 were approximately £11.1m (31 December 2008: £11.0m, 30 June 2009: £10.3m) after payment of £1.5dividends in the year.

Dividend

It is the Board's intention to recommend the payment of a final dividend, details of which will be provided at the time of the announcement of the final results for the year.

Announcement of final results

The detailed results for 2009 will be announced in accordance with Xaar's normal timetable on 17 March 2010.

Ends

CONTACTS

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance Director 

 

 

 

Singer Capital Markets Limited:

020-3205-7626

Shaun Dobson

 

 

 

Bankside Consultants:

 

Steve Liebmann

020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSEFEFSFSSEEF
Date   Source Headline
26th Apr 20215:51 pmRNSHolding(s) in Company
22nd Apr 202112:18 pmRNSDirector Declaration
15th Apr 20212:24 pmRNSNotice of 2020 Preliminary Results
6th Apr 202112:12 pmRNSHolding(s) in Company
1st Apr 20211:50 pmRNSTotal Voting Rights
1st Mar 20215:18 pmRNSTotal Voting Rights
10th Feb 20212:25 pmRNSHolding(s) in Company
1st Feb 202111:01 amRNSTotal Voting Rights
28th Jan 20212:49 pmRNSHolding(s) in Company
21st Jan 202110:27 amRNSHolding(s) in Company
14th Jan 20217:00 amRNSTrading Statement
4th Jan 202111:38 amRNSTotal Voting Rights
1st Dec 20204:43 pmRNSTotal Voting Rights
9th Nov 202010:42 amRNSHolding(s) in Company
4th Nov 202011:00 amRNSUpdate on cyber security incident
3rd Nov 202011:29 amRNSGrant of options under SAYE Scheme
3rd Nov 202011:15 amRNSHolding(s) in Company
2nd Nov 202011:40 amRNSTotal Voting Rights
7th Oct 20207:00 amRNSNotice of cyber security incident
6th Oct 20204:48 pmRNSHolding(s) in Company
1st Oct 202012:59 pmRNSTotal Voting Rights
30th Sep 20207:00 amRNS2020 Interim Results
3rd Sep 20204:24 pmRNSHolding(s) in Company
3rd Sep 20201:20 pmRNSNotice of Interim Results
1st Sep 202010:42 amRNSTotal Voting Rights
5th Aug 202012:47 pmRNSTotal Voting Rights
3rd Aug 20208:59 amRNSChange of Adviser
16th Jul 20207:00 amRNSTrading Statement
9th Jul 20204:36 pmRNSPrice Monitoring Extension
1st Jul 20203:17 pmRNSConfirmation of Board Change & Succession
1st Jul 202011:47 amRNSTotal Voting Rights
5th Jun 20207:00 amRNSGrant of Options
2nd Jun 202011:16 amRNSTotal Voting Rights
2nd Jun 202011:13 amRNSResult of AGM
2nd Jun 20207:00 amRNSTrading Statement
15th May 202010:59 amRNSHolding(s) in Company
7th May 20207:00 amRNSNotice of Annual General Meeting
1st May 20203:10 pmRNSTotal Voting Rights
30th Apr 20202:27 pmRNSHolding(s) in Company
29th Apr 202012:04 pmRNSDisclosure of Rights attached to Equity Shares
29th Apr 202011:41 amRNSGrant of option
28th Apr 20205:27 pmRNSHolding(s) in Company
27th Apr 20202:23 pmRNSHolding(s) in Company
27th Apr 20202:00 pmRNSDirectorate Change - Appointment
24th Apr 20203:10 pmRNSHolding(s) in Company
24th Apr 20203:02 pmRNSAnnual Financial Report
23rd Apr 20202:35 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSAnnual Financial Report
9th Apr 20209:15 amRNSHolding(s) in Company
6th Apr 20203:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.